PARP激活在糖尿病牙周炎发病中的作用
本研究在大鼠实验性牙周炎模型中探讨PARP激活在糖尿病牙周炎发病中的作用,并评估PARP抑制剂1,5-异喹啉二醇的治疗效果。结果显示糖尿病合并牙周炎大鼠牙龈PARP激活最高,炎症细胞浸润、炎症基因表达及牙槽骨丧失均显著增加,而PARP抑制剂可抑制上述改变。结论提示PARP激活参与糖尿病牙周炎的发病与加重,PARP抑制可能成为治疗糖尿病牙周炎的潜在策略。
要点
- 糖尿病合并牙周炎大鼠牙龈PARP激活水平最高。
- PARP抑制剂可抑制糖尿病牙周炎大鼠的牙龈炎症和牙槽骨丧失。
- PARP激活参与糖尿病牙周炎的发病与加重。
核心结论
- PARP激活参与糖尿病牙周炎的发病和加重,PARP抑制对糖尿病牙周炎具有治疗潜力。
研究设计与样本
- 研究采用大鼠实验性牙周炎模型,通过尼龙线结扎诱导牙周炎。
- 正常和糖尿病大鼠各半数接受PARP抑制剂1,5-异喹啉二醇治疗2周。
- 通过免疫染色检测牙龈聚ADP-核糖以评估PARP激活。
- 通过牙龈炎症细胞浸润、炎症基因表达和micro-CT分析评估牙周炎。
主要发现
- 牙周炎和糖尿病均增加牙龈PARP激活,糖尿病合并牙周炎大鼠PARP激活最高。
- 糖尿病合并牙周炎大鼠牙龈单核/巨噬细胞浸润、炎症基因表达、硝基酪氨酸阳性细胞及牙槽骨丧失均显著增加。
- PARP抑制剂治疗可抑制上述糖尿病合并牙周炎大鼠的各项改变。
临床怎么用
- PARP抑制可能作为糖尿病牙周炎患者的潜在治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: The aetiology of progressive periodontitis in diabetes has not yet been elucidated. We previously demonstrated that nitrosative stress is increased in diabetic rats with periodontitis. Nitrosative stress induces poly(ADP-ribose) polymerase (PARP) activation. Here, we demonstrated the involvement of PARP activation in diabetic periodontitis and detailed the therapeutic effects of PARP inhibitor. MATERIALS AND METHODS: Experimental periodontitis was induced by placing a nylon thread ligature. Half of the normal and diabetic rats received the PARP inhibitor, 1,5-isoquinolinediol, for 2 weeks. Gingival PARP activation was detected by immunostaining for poly(ADP-ribose). Periodontitis was evaluated by gingival inflammatory cell infiltration, inflammatory gene expressions and micro-CT analyses. RESULTS: Although both periodontitis and the presence of diabetes increased PARP activation in the gingiva, diabetic rats with periodontitis had the highest activation of PARP. Diabetic rats with periodontitis also showed significant increases in monocyte/macrophage invasion into the gingiva, inflammatory gene expressions, nitrotyrosine-positive cells in the gingiva and alveolar bone loss, all of which were suppressed by treatment with the PARP inhibitor. CONCLUSIONS: These results indicate the involvement of PARP activation in the pathogenesis and aggravation of periodontal disease in diabetes and suggest the therapeutic potential of PARP inhibition for treating periodontal disease, especially in patients with diabetes.
引用
- Adachi K, Miyajima SI, Nakamura N, et al. Role of poly(ADP-ribose) polymerase activation in the pathogenesis of periodontitis in diabetes. J Clin Periodontol. 2017. PMID: 28570002. doi:10.1111/jcpe.12758
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。